Objective: To discuss the mechanism of action and nursing care of adults receiving chimeric antigen receptor (CAR) T-cell therapy.
Data Source: Peer reviewed articles and pharmaceutical drug labels.
Conclusion: CAR T-cell therapy is among the most exciting therapies in the evolution of cancer treatment.
Objective: To discuss current recommendations and resources for nurses to ensure they advocate for patients with cytokine release syndrome (CRS).
Data Sources: A literature search using key terms: cytokine release syndrome, neurotoxicity, CAR T, adverse events.
Conclusion: Chimeric antigen receptor (CAR) T-cell immunotherapy is a growing and rapidly changing field of research.